<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05119608</url>
  </required_header>
  <id_info>
    <org_study_id>2021-05128</org_study_id>
    <nct_id>NCT05119608</nct_id>
  </id_info>
  <brief_title>Treatment of Post-covid Syndrome in Patients Treated in Intensive Care</brief_title>
  <official_title>Detection and Treatment of Long-term Symptoms - Post-covid Syndrome - in Patients Who Have Been Treated in Intensive Care for COVID-19.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Skane</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Region Stockholm</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lund University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Region Skane</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study is a randomized controlled trial, which identifies and diagnoses mental&#xD;
      health problems in survivors of critical COVID-19 infection at 12 months post-ICU care, and&#xD;
      randomize patients to either an ACT-enforced CBT intervention, or to treatment as usual.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Specifically, the present study aims to&#xD;
&#xD;
        1. investigate early predictors (during ICU-care) of post-covid syndrome occurring at 3-6&#xD;
           months, 12 months, and 36 months, respectively, including cognitive and mental health&#xD;
           problems,&#xD;
&#xD;
        2. deepen the understanding of mental health symptoms in ICU-treated COVID-19 survivors,&#xD;
           mental health-related treatment seeking, changes in addictive behaviors, and the&#xD;
           diagnostic meaning of mental health symptoms expressed in COVID-19 survivors, and&#xD;
&#xD;
        3. conduct a clinical treatment study with the following research question: for patients&#xD;
           with post-covid mental health symptoms after 12 months, can an intervention of Cognitive&#xD;
           Behavioral Therapy (CBT) with Acceptance and Commitment Therapy (ACT), when compared to&#xD;
           standard clinical care (referral to primary care), improve the outcome of post-covid&#xD;
           anxiety symptoms and secondary other symptoms of poor mental health and quality of life?&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 15, 2021</start_date>
  <completion_date type="Anticipated">November 15, 2025</completion_date>
  <primary_completion_date type="Anticipated">November 15, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>1:1 randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Study of a psycho-therapeutic intervention vs treatment as usual, therefore no masking of the treatment given.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of HADS anxiety score</measure>
    <time_frame>3 months post-treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction of HADS depression score</measure>
    <time_frame>2 weeks, 3 and 12 months post-treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of HADS anxiety score</measure>
    <time_frame>2 weeks and 12 months post-treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improved mental health-related quality of life</measure>
    <time_frame>2 weeks, 3 and 12 months post-treatment</time_frame>
    <description>Improved mental health component summary score of SF-36v2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduced fatigue</measure>
    <time_frame>2 weeks, 3 and 12 months post-treatment</time_frame>
    <description>Modified Fatigue Impact Scale (MFIS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduced post-traumatic symptoms</measure>
    <time_frame>2 weeks, 3 and 12 months post-treatment</time_frame>
    <description>Posttraumatic Stress Disorder Checklist (PCL-5) scale</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Patient satisfaction with therapy intervention</measure>
    <time_frame>2 weeks post-treatment</time_frame>
    <description>Therapy and Therapist Scale-Revised (STTS-R)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>COVID-19</condition>
  <condition>Mental Health Disorder</condition>
  <arm_group>
    <arm_group_label>CBT/ACT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cognitive-behavioral therapy intervention with principal components of acceptance and commitment therapy (ACT)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TAU</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment as usual, defined by standard care, i.e. referral to relevant health care provider (typically primary care).</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CBT/ACT</intervention_name>
    <description>10-session ACT-re-enforced CBT intervention.</description>
    <arm_group_label>CBT/ACT</arm_group_label>
    <arm_group_label>TAU</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  COVID-19 survivors who screen positive for clinical anxiety or depression, defined as&#xD;
             reaching a score of ≥ 8 on either the anxiety or depression sub-scales within the&#xD;
             questionnaire HADS at the standard 12-months follow-up&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Conditions in which patients are acutely suicidal, psychotic, suffering from a mental&#xD;
             disorder requiring in-patient psychiatric treatment, opposed to receiving a&#xD;
             psycho-therapeutic intervention, or with cognitive problems or language difficulties&#xD;
             which are judged to be too extensive for the informed consent procedure and for a&#xD;
             psycho-therapeutic intervention&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Anders Håkansson, PhD</last_name>
    <phone>+46 46 175596</phone>
    <email>anders_c.hakansson@med.lu.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Psychiatry Skåne, Malmö-Trelleborg deparment of psychiatry</name>
      <address>
        <city>Malmö</city>
        <zip>205 02</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <contact>
      <last_name>Katarina Hartman</last_name>
      <email>katarina.hartman@skane.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Södersjukhuset AB, Region Stockholm</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <contact>
      <last_name>Maria Cronhjort, PhD</last_name>
      <email>maria.cronhjort@sll.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 11, 2021</study_first_submitted>
  <study_first_submitted_qc>November 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 15, 2021</study_first_posted>
  <last_update_submitted>November 11, 2021</last_update_submitted>
  <last_update_submitted_qc>November 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Region Skane</investigator_affiliation>
    <investigator_full_name>Anders C Håkansson</investigator_full_name>
    <investigator_title>MD, professor</investigator_title>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>mental health disorder</keyword>
  <keyword>cognitive-behavioral therapy</keyword>
  <keyword>acceptance and commitment therapy</keyword>
  <keyword>addictive behavior</keyword>
  <keyword>ICU</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

